Amneal Pharmaceuticals, Inc. (AMRX) › Net IncomeAmneal Pharmaceuticals, Inc. (AMRX) — Net IncomeAnnual figures by period end, from SEC filings.2016-12-31: $02017-12-31: $02018-12-31: -$19.74M2019-12-31: -$603.57M2020-12-31: $67.79M2021-12-31: $13.16M2022-12-31: -$270.58M2023-12-31: -$83.99M2024-12-31: -$116.89M2025-12-31: $72.06M$72.06M2016-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31$72.06M—2026-02-27From 2025-01-012024-12-31-$116.89M—2026-02-27From 2024-01-012023-12-31-$83.99M—2026-02-27From 2023-01-012022-12-31-$270.58M-2155.6%2024-03-14From 2022-01-012021-12-31$13.16M-80.6%2024-03-14From 2021-01-012020-12-31$67.79M—2023-03-03From 2020-01-012019-12-31-$603.57M—2022-03-01From 2019-01-012018-12-31-$19.74M—2021-03-01From 2018-01-012017-12-31$0—2020-03-02From 2017-01-012016-12-31$0—2019-03-01From 2016-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)